DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the field of biopharmaceuticals, providing promising breakthroughs across various healthcare and industrial apps. With its structural similarity to By natural means derived human serum albumin, OsrHSA offers a safer, much more trusted alternative for therapeutic use